SAIT-301 |
SAIT-301 |
Phase 1 Clinical |
|
Neoplasms |
Details
|
NP-01 (Shijiazhuang No.4 Pharmaceutical/Nanjing Nadingfei Medical Technology) |
NP-01 |
Phase 1 Clinical |
Shijiazhuang No 4 Pharmaceutical Co Ltd, Nanjing Nadingfei Pharmaceutical Technology Co Ltd |
Liver Neoplasms; Solid tumours; Stomach Neoplasms; Lung Neoplasms |
Details
|
LMV-12(HE003) |
LMV-12(HE003) |
Phase 1 Clinical |
Nanchang Hongyi Technology Co Ltd |
Solid tumours |
Details
|
Pamufetinib |
TAS-115 |
Phase 1 Clinical |
Otsuka Pharmaceutical Co Ltd, Taiho Pharmaceutical Co Ltd |
Neoplasms |
Details
|
NP-107 |
NP107; NP-107 |
Phase 1 Clinical |
Shanghai Nawei Biotechnology Co Ltd |
Solid tumours |
Details
|
Boxitinib Hydrochloride |
|
Phase 1 Clinical |
Hec Pharm Co Ltd |
Stomach Neoplasms; Carcinoma, Renal Cell; Breast Neoplasms; Glioma; Lung Neoplasms |
Details
|
Alirinetide |
GM-606; GM-607; GM-608; GM-609; GM-6; GM-600; GM-602; GM-603; GM-604; GM-605 |
|
Genervon Biopharmaceuticals Llc |
|
Details
|
LM-061 |
LM-061 |
Phase 1 Clinical |
Shanghai Lixin Pharmaceutical Research and Development Co Ltd |
Solid tumours |
Details
|
HTI-1066 |
HTI-1066 |
|
Jiangsu Hengrui Medicine Co Ltd |
|
Details
|
SGX-523 |
SGX-523 |
|
Eli Lilly And Company |
|
Details
|
HLX-55 |
HLX-55; KTN-0216 |
Phase 1 Clinical |
Kolltan Pharmaceuticals Inc |
Solid tumours |
Details
|
BPI-9016 |
BPI-9016; BPI-9016M |
Phase 1 Clinical |
Betta Pharmaceuticals Co Ltd |
Solid tumours; Carcinoma, Non-Small-Cell Lung |
Details
|
EMD-1204831 |
EMD-1204831 |
|
Merck Serono |
|
Details
|
PF-04217903 |
PF-4217903; PF-04217903; PF-4217903-A |
|
Pfizer Pharmaceuticals Ltd (China) |
|
Details
|
JNJ-38877605 |
JNJ-38877605 |
|
Johnson & Johnson |
|
Details
|
c-Met/PD-L1 CAR-T cell (The Second Hospital of Nanjing Medical University) |
|
|
The Second Hospital Of Nanjing Medical University |
|
Details
|
Anti-cMet SIMPLE Antibody |
ARGX-111 |
|
Argenx Se |
|
Details
|
Metatinib Trometamol |
BMS-817378; SIM-817378 |
Phase 1 Clinical |
Bristol-Myers Squibb Company |
Solid tumours; Liver Neoplasms; Stomach Neoplasms; Colorectal Neoplasms |
Details
|
QBH-196 |
QBH-196 |
Phase 1 Clinical |
Shenyang Pharmaceutical University |
Solid tumours; Stomach Neoplasms |
Details
|
Kanitinib |
CX-1003 |
Phase 1 Clinical |
Beijing Konruns Pharmaceutical Co Ltd, Guangzhou Yingsheng Bio Technology Co Ltd |
Solid tumours |
Details
|
CKD-702 |
|
Phase 1 Clinical |
Chong Kun Dang Pharmaceutical Corp |
Carcinoma, Non-Small-Cell Lung |
Details
|
Fosgonimeton |
ATH-1017; NDX-1017 |
Phase 3 Clinical |
M3 Biotechnology |
Alzheimer Disease; Lewy Body Disease |
Details
|
REGN-5093-M114 |
METxMET-M114; REGN5093-M114 |
Phase 2 Clinical |
Regeneron Pharmaceuticals Inc |
Carcinoma, Non-Small-Cell Lung |
Details
|
REGN-5093 |
REGN-5093 |
Phase 2 Clinical |
Regeneron Pharmaceuticals Inc |
Carcinoma, Non-Small-Cell Lung |
Details
|
BYON-3521 |
BYON-3521 |
Phase 1 Clinical |
Byondis Bv |
Solid tumours; Neoplasms |
Details
|
TR1801-ADC |
MT-8633; TR1801-ADC |
Phase 1 Clinical |
Tanabe Research Laboratories U.S.A. Inc |
Solid tumours |
Details
|
ASKC-202 |
ASKC202 |
Phase 1 Clinical |
|
Solid tumours |
Details
|
Recombinant plasmid-hepatocyte growth factor |
Pudk-HGF |
Phase 3 Clinical |
Academy Of Military Medical Sciences, Wuhan Optical Valley Humanwell Biological Pharmaceutical Co Ltd |
Ischemia; Peripheral Arterial Disease |
Details
|
Elzovantinib |
TPX-0022 |
Phase 2 Clinical |
Turning Point Therapeutics Inc |
Solid tumours; Stomach Neoplasms; Carcinoma, Non-Small-Cell Lung |
Details
|
AL-2846 |
AL-2846 |
Phase 2 Clinical |
Jiangsu Chia Tai-Tianqing Pharmaceutical Co Ltd, Advenchen Laboratories Nanjing Ltd |
Bone metastases; Liver Neoplasms; Stomach Neoplasms; Neurofibromatoses; Neoplasms; Pancreatic Neoplasms; Neurofibroma; Ganglioglioma; Medullary thyroid cancer (MTC); Prostatic Neoplasms; Colorectal Neoplasms; Neurilemmoma; Carcinoma, Non-Small-Cell Lung; Neurofibromatosis 1 |
Details
|
Emibetuzumab |
LA-480; LY-2875358 |
Phase 2 Clinical |
Eli Lilly And Company |
Solid tumours; Liver Neoplasms; Stomach Neoplasms; Carcinoma, Renal Cell; Esophageal Neoplasms; Neoplasms; Lymphoma; Carcinoma, Non-Small-Cell Lung; Adenocarcinoma |
Details
|
SPH3348 |
SPH-3348 |
Phase 1 Clinical |
Shanghai Pharmaceuticals Holding Co Ltd |
Solid tumours; Neoplasms |
Details
|
GB-263 |
GB-263; GB-263T |
Phase 2 Clinical |
Genor Biopharma Co Ltd |
Solid tumours; Neoplasms; Carcinoma, Non-Small-Cell Lung |
Details
|
Glesatinib |
7Q29OXD98N; MG-90265H9; MG-90265gly; MG-90265; MG-90265X; MGCD-265 |
Phase 2 Clinical |
Mirati Therapeutics Inc |
Neoplasms; Carcinoma, Non-Small-Cell Lung |
Details
|
ABN-401 |
ABN-401; KDDF-201603-08 |
Phase 2 Clinical |
Abion Inc |
Solid tumours; Neoplasms |
Details
|
CM-118 |
CM-118 |
Phase 1 Clinical |
Xcovery |
Neoplasms; Carcinoma, Non-Small-Cell Lung |
Details
|
Merestinib |
LY-2801653; 5OGS5K699E |
Phase 2 Clinical |
Eli Lilly And Company |
Bone metastases; Solid tumours; Biliary Tract Neoplasms; Skin Melanoma; Pancreatic Neoplasms; Neoplasms; Microsatellite instability-high cancer; Breast Neoplasms; Lymphoma, Mantle-Cell; Cholangiocarcinoma; Colorectal Neoplasms; Lymphoma, Non-Hodgkin; Gallbladder Neoplasms; Leukemia, Myeloid, Acute; Neoplasm Metastasis; Carcinoma, Non-Small-Cell Lung |
Details
|
HS-10241 |
HS-10241 |
Phase 1 Clinical |
Jiangsu Hansoh Pharmaceutical Group Co Ltd |
Solid tumours; Carcinoma; Neoplasms; Carcinoma, Non-Small-Cell Lung |
Details
|
Bafisontamab |
FIT-013a; EMB-01 |
Phase 2 Clinical |
Shanghai Epimab Biotherapeutics, Inc |
Liver Neoplasms; Biliary Tract Neoplasms; Carcinoid Tumor; Stomach Neoplasms; Neoplasms; Digestive System Neoplasms; Colorectal Neoplasms; Lung Neoplasms; Carcinoma, Non-Small-Cell Lung; Neoplasm Metastasis; Gastrointestinal Neoplasms; Carcinoma, Hepatocellular |
Details
|
MCLA-129 |
MCLA-129 |
Phase 2 Clinical |
Merus Nv |
Solid tumours; Head and Neck Neoplasms; Stomach Neoplasms; Colorectal Neoplasms; Carcinoma, Non-Small-Cell Lung |
Details
|
TAVO-412 |
TAVO-412 |
Phase 1 Clinical |
Tavotek Biotherapeutics (Hong Kong) Ltd |
Neoplasms |
Details
|
EMI-137 |
EMI-137; GE-137 |
Phase 2 Clinical |
Ge Healthcare |
Esophageal Neoplasms; Colonic Neoplasms; Barrett Esophagus |
Details
|
GST-HG161 |
GST-HG161 |
Phase 1 Clinical |
Wuxi Apptec Co Ltd, Fujian Cosunter Pharmaceutical Co Ltd |
Solid tumours; Neoplasms; Carcinoma, Hepatocellular |
Details
|
Telisotuzumab vedotin |
ABT-399; ABBV-399 |
Phase 3 Clinical |
Abbvie Inc |
Solid tumours; Carcinoma, Non-Small-Cell Lung |
Details
|
XL-092 |
XL-092 |
Phase 3 Clinical |
Exelixis Inc |
Solid tumours; Carcinoma, Renal Cell; Neoplasms; Carcinoma, Transitional Cell; Prostatic Neoplasms, Castration-Resistant; Breast Neoplasms; Colorectal Neoplasms |
Details
|
Ningetinib Tosylate |
CT-053-PTSA; CT-053 |
Phase 2 Clinical |
Hec Pharm Co Ltd |
Solid tumours; Intestinal Neoplasms; Stomach Neoplasms; Carcinoma, Renal Cell; Lung Neoplasms; Leukemia, Myeloid, Acute; Carcinoma, Non-Small-Cell Lung |
Details
|
RC-108 |
RC-108; RC108 |
Phase 2 Clinical |
RemeGen Co Ltd |
Solid tumours; Digestive System Neoplasms; Gastrointestinal Neoplasms |
Details
|
Sitravatinib |
IND-155305; MG-516; MG-91516; MGCD-516 |
Phase 3 Clinical |
Mirati Therapeutics Inc |
Breast Neoplasms; Carcinoma, Hepatocellular; Gastrointestinal Neoplasms; Uterine Cervical Neoplasms; Carcinoma, Non-Small-Cell Lung; Lung Neoplasms; Carcinoma, Squamous Cell; Mouth Neoplasms; Endometrial Neoplasms; Esophageal Squamous Cell Carcinoma; Hepatic Insufficiency; Ureteral Neoplasms; Kidney Neoplasms; Liposarcoma; Lung Diseases; Uveal melanoma; Triple Negative Breast Neoplasms; Carcinoma, Transitional Cell; Neoplasms; Carcinoma; Squamous Cell Carcinoma of Head and Neck; Carcinoma, Renal Cell; Biliary Tract Neoplasms; Solid tumours |
Details
|
Refanalin |
ANG-3777; BB-3; SNV-003 |
Phase 3 Clinical |
Vifor Pharma Ag, Angion Biomedica Corp |
Pneumonia; Myocardial Infarction; Coronavirus Disease 2019 (COVID-19); Delayed Graft Function; Acute Kidney Injury |
Details
|
CBT-101 |
CBT-101 |
Phase 1 Clinical |
|
Solid tumours |
Details
|
AMG-337 |
AMG-337 |
Phase 2 Clinical |
Amgen Inc |
Solid tumours; Esophageal Neoplasms; Stomach Neoplasms; Neoplasms; Sarcoma, Clear Cell; Esophageal adenocarcinoma; Adenocarcinoma; Gastrointestinal Neoplasms |
Details
|